Navigation Links
Possible genetic predictor for response to lithium augmentation in depressed patients
Date:12/6/2007

Philadelphia, PA, December 6, 2007 As in most fields of medicine, psychiatry researchers are working to identify specific types of patients, through their individual genetic variations, that may better benefit from particular drugs or combinations of drugs than other patients. A new study, published in Biological Psychiatrys December 1st issue, investigated whether depressed patients with a particular genetic variation would better respond to the addition of lithium to their treatment regimen, as opposed to an antidepressant-only treatment.

Adli and colleagues recruited acutely depressed patients who were unresponsive to an antidepressant-only treatment, and augmented their therapy with lithium, the most common medication used to treat bipolar disorder. They then genotyped these patients for variations in the GSK3B gene. This gene codes for the enzyme glycogen synthase kinase 3-beta, which is inhibited by lithium. Mazda Adli, M.D., corresponding author on the project, explains their findings: [We] found that antidepressant non-responders with depression show a significantly better response to a subsequent lithium augmentation if they carry at least one C-allele as opposed those patients carrying two T-alleles, which is in line with the previous findings regarding this genetic polymorphism. In other words, patients who carried a specific genetic variation, the C-allele, were more likely to get better with the addition of lithium to their treatment than patients with other variations of the GSK3B gene.

John H. Krystal, M.D., Editor of Biological Psychiatry and affiliated with both Yale University School of Medicine and the VA Connecticut Healthcare System, comments, Over the past several years, preclinical studies have suggested that GSK3-beta was a key molecular switch related to the clinical effectiveness of lithium. This hypothesis is supported by this report from Adli et al. They find that variation in the GSK3-beta gene is related
'/>"/>

Contact: Jayne Dawkins
ja.dawkins@elsevier.com
215-239-3674
Elsevier
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Fairbank Farms Voluntarily Recalls 85% Ground Round Beef Patties Sold Fresh from Shaws Due to Possible Health Risk
2. M.D. Anderson-led team reports possible key to autoimmune disease
3. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
4. Possible safer target for anti-clotting drugs found
5. Jefferson researchers uncover new evidence of prolactins possible role in breast cancer
6. Why it is impossible for some to just say no
7. Saving Millions of Childrens Lives Is Possible
8. Mayo Clinic Proceedings article explores possible link between obesity and viral infections
9. Mayo Clinic reports possible new therapy for patients with platinum-resistant ovarian cancer
10. Help for California Fire Evacuees Possible Through Partnership for Prescription Assistance
11. Mayo Clinic study points to a possible biomarker for colon cancer in people 50 and under
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... The Dr. Hector P. Garcia Memorial Foundation, ... proposed naming of the new primary care facility in ... Health Center. , The proposed 40,000 sq. ft. facility ... chronic disease management programs, pharmacy services and wellness and ... home model center. , Dr. Hector P. Garcia, for ...
(Date:7/30/2014)... July 30, 2014 Decene is ... a chain of ten carbon atoms with one ... typical of 1-decenes. It can be used as ... intermediate to produce epoxides, amines, oxo alcohols, synthetic ... , Early buyers will receive 10% customization on ...
(Date:7/30/2014)... -- Medical costs for chronic obstructive pulmonary disease (COPD) ... each year, according to new research from the U.S. ... financial toll of COPD (which includes emphysema and chronic ... by 2020. "For the first time, our analyses ... health practitioners with estimates of the economic burden of ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 The global digital ... 2013 and is expected to grow at a CAGR of ... The demand for digital pathology is growing and is expected ... The use of scanners and image analysis software enable pathologists ... for patients. , In 2013, the North American market was ...
(Date:7/30/2014)... Los Angeles, CA (July 30, 2014) With the ... has become a popular science and researchers must ... in the study of stroke rehabilitation. A new ... discusses a systematic shift in perspective and suggests ... brain would strongly promote stroke motor recovery, for ...
Breaking Medicine News(10 mins):Health News:Dr. Hector P Garcia Memorial Foundation Supports New Health Care Facility 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:Annual COPD Costs To Hit $49 Billion by 2020: CDC 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 4Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 5Health News:Neuro researchers advocate for a shift in thinking for stroke rehabilitation 2
... Rare Diseases, BETHESDA, Md., April 24 ... of Representatives for passing,legislation to reauthorize the Small ... testimony from Robert J. Beall, Ph.D., president and ... requiring that,special attention be given to research for ...
... The following are,excerpts from an article in The ... Republican National Committee:, Congressional Democrats are backing away ... saying that even if,their party controls the White House ... some senators, the promises made by Sens. Barack Obama ...
... (Nasdaq: ONXX ) today announced that it ... Conference on Thursday,May 1, at 8:00 a.m. Eastern ... of the presentation on our website at:, ... listeners log on 15 minutes early in order ...
... how brain cell communication may be altered in schizophrenia ... at the Medical College of Georgia, a 2008 Distinguished ... Alliance Eminent Scholar in Neuroscience and professor in the ... of 11 scientists to receive the award, which includes ...
... Perrigo Company,(Nasdaq: PRGO ; TASE) today announced that ... Administration (FDA) to market over-the-counter (OTC),Nicotine Polacrilex Gum USP, ... The FDA has determined the product to be ... mg (base) and 4 mg,(base), which is an aid ...
... April 24 Karen Ignagni,President and CEO ... issued,the following statement commending the Senate on ... Senate:, (Logo: http://www.newscom.com/cgi-bin/prnh/20040830/AHIPLOGO ), ... the basis of their genetic,makeup. We applaud ...
Cached Medicine News:Health News:Cystic Fibrosis Foundation Lauds Congress for Passage of Small Business Innovation Research Program 2Health News:RNC: Dems Hedge on Healthcare 2Health News:Dr. Mei honored by mental health research charity for schizophrenia studies 2Health News:Dr. Mei honored by mental health research charity for schizophrenia studies 3Health News:Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum 2
(Date:7/30/2014)... 2014 Cynosure, Inc. (NASDAQ: ... for non-invasive and minimally invasive applications, today announced that the ... Officer and Chief Financial Officer Timothy W. Baker ... 53, will continue to serve as CFO and will take ... remains Chairman and Chief Executive Officer. "Tim ...
(Date:7/30/2014)... -- Packaging Coordinators, Inc. (PCI) is pleased to announce it ... Services Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... United Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug ... form manufacturing, as well as Clinical Packaging, Labeling, and ...
(Date:7/30/2014)... MIAMI , July 30, 2014   Medical ... they have been awarded a Department of Defense (US ... months to supply a mobile MRI diagnostic machine and ... Small Business (WOSB) through the Small Business Administration (SBA), ... in the field with the latest medical diagnostic equipment. ...
Breaking Medicine Technology:Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... Inc. today announced publication of results from a pivotal ... the treatment of breakthrough cancer pain (BTCP). The article, ... Pectin Nasal Spray (FPNS) in the treatment of breakthrough ... the peer-reviewed journal from the International Association for the ...
... October 4, 2010 ... ... var shortURL ... longUrl, so we need to grab the first one. for (var r in data.results) { first_result = ...
Cached Medicine Technology:Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain 2Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain 335th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 235th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 335th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 435th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 535th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 635th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 735th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 835th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 935th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 1035th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 1135th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser 12
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: